Notes - Segment Information, Etc.

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7247022

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
87,150,472,000 JPY
87,311,137,000 JPY
160,664,000 JPY
28,179,566,000 JPY
58,970,905,000 JPY
87,311,137,000 JPY
JPY
75,570,336,000 JPY
49,571,565,000 JPY
154,738,000 JPY
JPY
75,725,075,000 JPY
25,998,771,000 JPY
75,725,075,000 JPY
Transactions with other segments
9,036,000 JPY
546,556,000 JPY
537,519,000 JPY
109,000 JPY
8,926,000 JPY
JPY
-546,556,000 JPY
13,797,000 JPY
13,688,000 JPY
596,435,000 JPY
-610,233,000 JPY
JPY
109,000 JPY
610,233,000 JPY
Other items
Depreciation
6,626,055,000 JPY
6,717,350,000 JPY
91,295,000 JPY
855,716,000 JPY
5,770,338,000 JPY
6,843,170,000 JPY
125,820,000 JPY
6,126,989,000 JPY
5,262,593,000 JPY
89,116,000 JPY
125,086,000 JPY
6,341,193,000 JPY
864,396,000 JPY
6,216,106,000 JPY
Increase in property, plant and equipment and intangible assets
2,348,810,000 JPY
2,425,289,000 JPY
76,479,000 JPY
375,409,000 JPY
1,973,401,000 JPY
2,874,505,000 JPY
449,215,000 JPY
3,555,131,000 JPY
2,726,222,000 JPY
35,539,000 JPY
626,757,000 JPY
4,217,428,000 JPY
828,909,000 JPY
3,590,671,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.